The role of perioperative cardiorespiratory support in post infarction ventricular septal rupture-related cardiogenic shock

Autor: David Toral, Eva Santafosta, Arnau Blasco-Lucas, Oriol Alegre, Victòria Lorente, José González-Costello, Fabrizio Sbraga, Albert Ariza-Solé, Daniel Ortiz, Angel Cequier, Albert Miralles, José C. Sánchez-Salado, Jacobo Toscano, Andrea Izquierdo
Rok vydání: 2018
Předmět:
Male
medicine.medical_specialty
medicine.medical_treatment
Multiple Organ Failure
Myocardial Infarction
Shock
Cardiogenic

Infarction
030204 cardiovascular system & hematology
Critical Care and Intensive Care Medicine
Perioperative Care
Ventricular Function
Left

Ventricular Septal Rupture
03 medical and health sciences
0302 clinical medicine
Extracorporeal Membrane Oxygenation
Risk Factors
Internal medicine
medicine
Extracorporeal membrane oxygenation
Humans
cardiovascular diseases
030212 general & internal medicine
Myocardial infarction
Hospital Mortality
Lactic Acid
Aged
Retrospective Studies
Aged
80 and over

Ejection fraction
business.industry
Cardiogenic shock
Alanine Transaminase
Stroke Volume
General Medicine
Perioperative
Middle Aged
medicine.disease
Treatment Outcome
Ventricular assist device
Case-Control Studies
Creatinine
Practice Guidelines as Topic
Cardiology
Female
Heart-Assist Devices
Cardiology and Cardiovascular Medicine
business
Zdroj: European heart journal. Acute cardiovascular care. 9(2)
ISSN: 2048-8734
Popis: Background: Current guidelines recommend emergency surgical correction in patients with post infarction ventricular septal rupture (PIVSR), but patients with multiorgan failure are commonly managed conservatively because of high surgical risk. We assessed characteristics and outcomes of operated PIVSR patients with or without the use of short-term ventricular assist devices (ST-VADs). We also assessed the impact of a ST-VAD on the performance of surgery Methods: We retrospectively analysed all consecutive patients with PIVSR between January 2004 and May 2017. Baseline clinical characteristics, use of ST-VAD and performance of surgery during admission were assessed. The main outcome measured was in-hospital mortality. Results: A total of 28 patients were included. Mean age was 69.2 years. Most patients (20/28, 71.4%) underwent surgical repair. ST-VADs were used in 11/28 patients (39.3%). This percentage progressively increased across the study period, from 22.2% (2/9) in 2004–2011 to 58.3% (7/12) in 2015–2017 ( p=0.091). Patients undergoing ST-VAD use had poorer INTERMACS status, higher values of creatinine, lactate and alanine aminotransferase and lower left ventricular ejection fraction as compared with operated patients without support. In-hospital mortality did not differ according to the use of ST-VADs in operated patients (27.3% without ST-VAD vs. 22.2% with ST-VAD, p=0.604). All five patients undergoing early preoperative venoarterial extracorporeal membrane oxygenator support and delayed surgery survived at hospital discharge. Conclusions: ST-VAD use increased in patients with PIVSR. Despite a higher risk profile in operated patients undergoing ST-VAD use, mortality was not significantly different in these patients. Early preoperative venoarterial extracorporeal membrane oxygenation should be considered for very high risk PIVSR patients.
Databáze: OpenAIRE